The CDC Board reviews and approves the CDC’s vision and mission which form part of the CDC’s Performance Agreement with GCG. The Performance Agreement covers CDC’s Charter Statement and Strategy Map, Performance Scorecards and Strategic Initiatives for the following year. On 04 November 2016, as part of its planning, after a thorough review and evaluation of the Performance Agreement for 2017, the CDC Board approved the same for submission to the GCG.
Moreover, as part of monitoring of Board of CDC’s corporate strategy, the targets set in the scorecard are being monitored on a regular quarterly basis during board meetings. For 2016, based on CDC’s 2nd quarter performance, CDC submitted its CY 2016 performance targets for renegotiation as approved by the Board on 09 September 2016 since there were factors beyond CDC’s control which affected CDC’s performance.